| |||
 | |||
 |
Hawthorn | ||
| |||
| |||
| |||
|
Creatine | ||
|
| |||
|
| U.S. Brand Names |
| Deconsal® Sprinkle®; Endal®; Sinupan® |
 |
| Generic Available |
|
No |
|
| Synonyms |
| Phenylephrine and Guaifenesin |
|
| Pharmacological Index |
|
Decongestant; Expectorant |
|
| Use |
|
Symptomatic relief of those respiratory conditions where tenacious mucous plugs and congestion complicate the problem such as sinusitis, pharyngitis, bronchitis, asthma, and as an adjunctive therapy in serous otitis media |
|
| Adverse Reactions |
|
See individual agents |
|
| Drug Interactions |
|
See individual agents |
|
| Mechanism of Action |
|
See individual agents |
|
| Usual Dosage |
|
Oral: Adults: 1 or 2 every 12 hours |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
Use with caution since phenylephrine is a sympathomimetic amine which could interact with epinephrine to cause a pressor response |
|
| Dental Health: Effects on Dental Treatment |
|
Guaifenesin: No effects or complications reported Phenylephrine: Up to 10% of patients could experience tachycardia, palpitations, and dry mouth; use vasoconstrictor with caution |
|
| Dosage Forms |
|
Capsule, sustained release: Deconsal® Sprinkle®: Guaifenesin 300 mg and phenylephrine hydrochloride 10 mg Sinupan®: Guaifenesin 200 mg and phenylephrine hydrochloride 40 mg Tablet, timed release (Endal®): Guaifenesin 300 mg and phenylephrine hydrochloride 20 mg |
|
|
Copyright © 2007 Drugs Area |
